Although many metastatic ACC tumor samples harbored mutations in the beta-catenin gene like primary ACC, other genes involving molecular pathways such as ERBB4, GPCR, RAR, and PDGFR signaling were also frequently mutated in metastatic ACC. The gene discussed is PDGFRB; the disease is adrenal cortex carcinoma.